Risteys ·

OMOP concept ID	Test name	Measurement unit (harmonized unit)	N people	N records	Missing measurement value	Harmonized value distribution	Test outcome NA N A AA L LL H HH
3011436	s-histab	— (—)	844	917	100.00%	Distribution not available
3011436	s-histab	u/ml (u/ml)	25	30	50.00%

LabWAS

N Cases

N Controls

-log₁₀(p)

cases

controls

cases

controls

unit

-log₁₀(p)

N cases

N controls

Respiratory diseases principally affecting the interstitium, IBD co-morbidites

28.22

76.53

1.0

—

u/ml

—

ILD, hospital admission 2, with pulmonary infections

7.83

32.74

1.1

—

u/ml

—

Fibromyalgia

8.27

31.22

1.1

—

Polyarthrosis

105

5.15

27.51

1.2

1.0

—

Infections, IBD-co-morbidities

9.34

21.20

1.1

1.0

—

COPD/asthma related infections

199

455

2.19

20.32

1.1

47.00

9.40

u/ml

—

COPD/asthma/ILD related infections

199

455

2.19

20.32

1.1

47.00

9.40

u/ml

—

Other peripheral vascular diseases

5.76

17.57

1.1

—

u/ml

—

Sleep apnoea

176

560

2.04

16.14

1.1

—

39.43

u/ml

—

Other necrotizing vasculopathies

6.46

15.37

1.2

1.1

—

Sciatica+with lumbago

101

384

2.42

15.22

1.1

—

37.60

u/ml

—

Disorders of thyroid, IBD co-morbidities

7.33

14.76

1.1

1.0

—

Sleep apnoea, including avohilmo

182

580

1.95

14.61

1.1

—

36.88

u/ml

—

Gastro-oesophageal reflux disease

130

523

2.15

14.60

1.1

—

35.83

u/ml

—

Asthma (diagnoses ohter than nonallergic)

157

677

1.93

13.08

1.1

—

31.00

u/ml

—

Disorders of lacrimal system

383

2.35

12.93

1.1

—

42.33

u/ml

—

Asthma-related infections

109

495

2.16

12.79

1.1

—

31.00

u/ml

—

Asthma, hospital admission 2, infections

109

495

2.16

12.79

1.1

—

31.00

u/ml

—

Gout

117

3.39

12.42

1.1

1.0

—

u/ml

—

Other intervertebral disc disorders

139

429

1.95

11.34

1.1

—

37.60

—

Complications of surgical and medical care, not elsewhere classified

170

657

1.77

10.65

1.1

—

36.88

u/ml

—

Lumbar disc prolapse

109

414

2.02

10.38

1.1

—

37.60

—

Other CVD (FINNGEN)

4.29

9.89

1.1

1.2

—

Continuous positive airway pressure

3.44

9.80

1.1

—

Asthma, hospital admissions , main diagnosis only

140

691

1.79

9.52

1.1

—

31.00

u/ml

—

All kidney diseases

166

659

1.72

9.47

1.1

—

31.00

u/ml

—

370

2.15

9.42

1.1

—

33.63

u/ml

—

Complications of procedures, not elsewhere classified

138

639

1.79

9.29

1.1

—

36.88

u/ml

—

Renal tubulo-interstitial diseases

146

617

1.76

9.20

1.1

—

31.00

u/ml

—

Juvenile rheumatoid arthirtis

18.81

8.95

1.1

1.0

—

Dermatitis due to substances taken internally

8.63

8.79

1.3

1.0

—

u/ml

—

Vasomotor and allergic rhinitis

298

2.21

8.50

1.0

1.1

—

27.29

—

Certolizumab pegol

14.68

8.22

1.3

1.2

—

u/ml

—

Undetermined asthma, excluding more controls

3.82

8.22

1.0

1.1

—

Heart failure and antihypertensive medication

100

2.82

8.19

1.1

—

Complications of medical and surgical care

123

641

1.77

8.14

1.1

—

36.88

u/ml

—

Carpal tunnel syndrome

104

496

1.85

7.97

1.1

—

45.33

u/ml

—

Erythema multiforme

13.17

7.89

1.2

—

u/ml

—

Undetermined asthma

3.64

7.71

1.0

1.1

—

Intracranial trauma

298

1.98

7.59

1.1

—

39.29

u/ml

—

Allergic rhinitis

232

2.26

7.18

1.0

1.1

—

30.17

—

Irritable bowel syndrome

224

2.28

7.06

1.0

1.1

—

42.33

u/ml

—

Osteopathies and chondropathies

467

1.84

7.02

1.1

—

40.71

u/ml

—

Concussion

287

2.02

7.00

1.1

—

39.29

u/ml

—

Other functional intestinal disorders

337

1.96

6.58

1.1

—

20.83

—

Migraine

355

1.87

6.54

1.1

—

31.33

u/ml

—

Vocal cord dysfunction

3.88

6.49

1.0

1.1

—

u/ml

—

Polyarthritis, unspecified

9.30

6.29

1.2

1.0

—

u/ml

—

Gonarthrosis,primary

137

521

1.62

6.28

1.1

—

24.00

—

Morphin

18.18

6.27

1.0

—

Asthma, including avohilmo

179

662

1.52

6.12

1.1

—

28.45

u/ml

—

Bleeding

123

533

1.64

6.12

1.1

—

25.50

u/ml

—

Alopecia areata

8.66

6.06

1.1

—

u/ml

—

Benign neoplasm of colon, rectum, anus and anal canal

490

1.72

5.95

1.0

1.1

—

26.80

u/ml

—

Chronic sinusitis

358

1.90

5.90

1.1

—

39.43

—

Surgical operation and other surgical procedures as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure

533

1.73

5.84

1.1

—

36.88

u/ml

—

Symptoms and signs involving the digestive system and abdomen

145

459

1.58

5.82

1.1

—

28.45

u/ml

—

Other headache syndromes

364

1.87

5.63

1.0

1.1

—

39.43

u/ml

—

Drug-induced systemic lupus erythematosus

13.29

5.62

1.9

1.3

—

Other hammer toe(s) (acquired)

2.77

5.56

1.1

1.0

—

Any operation in hilmo

+∞

5.51

1.1

0.0

—

Surgical and other medical procedures as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure

561

1.67

5.41

1.1

—

36.88

u/ml

—

Osteoporosis with pathological fracture (FG)

4.46

5.05

1.1

1.0

—

Acute sinusitis

424

1.73

5.03

1.1

—

23.83

—

Other nutritional deficiencies

103

605

1.60

4.98

1.1

—

28.45

u/ml

—

Other specified/unspecified necrotizing vasculopathies

11.58

4.80

1.0

1.3

—

Abdominal and pelvic pain

139

459

1.52

4.79

1.1

—

28.45

u/ml

—

Nausea and vomiting

199

2.07

4.70

1.1

—

39.67

u/ml

—

Migraine with aura

184

2.12

4.67

1.1

—

33.80

u/ml

—

Ischaemic heart disease, wide definition

112

444

1.56

4.56

1.1

—

26.80

u/ml

—

Constipation

130

600

1.50

4.50

1.1

—

33.11

—

Psoriasis (vulgaris), strict definition

5.83

4.44

1.4

1.1

—

u/ml

—

Hernia

137

623

1.47

4.35

1.1

—

36.88

u/ml

—

Diseases of inner ear

471

1.64

4.34

1.0

1.1

—

26.80

—

Bruxism

6.32

4.30

1.0

1.1

—

Drug-induced osteoporosis with pathological fracture

11.79

4.28

1.1

1.2

—

Obesity and other hyperalimentation

584

1.57

4.26

1.1

—

36.88

u/ml

—

Chronic diseases of tonsils and adenoids

113

469

1.52

4.17

1.1

—

32.33

—

Hypertensive Renal Disease

5.27

4.14

1.0

—

Obesity

583

1.56

4.09

1.1

—

36.88

u/ml

—

Pollen allergy

133

2.23

4.08

1.0

1.1

—

33.80

—

Pyogenic arthritis

4.63

4.05

1.1

1.0

—

Disorders of other endocrine glands

376

1.70

4.05

1.0

1.1

—

39.67

u/ml

—

Other crystal arthropathies

10.08

4.01

1.0

—

Crystal arthropathies, rheuma endpoint

10.08

4.01

1.0

—

Hallux rigidus

2.77

3.84

1.1

1.0

—

Later onset COPD, excluding more controls

2.44

3.81

1.0

1.1

—

Dermatopolymyositis

8.84

3.78

1.0

1.3

—

u/ml

—

Prurigo nodularis

8.81

3.77

1.4

1.1

—

Disorders of the thyroid gland

133

604

1.43

3.71

1.1

—

23.67

u/ml

—

Artificial joint operation, meniscal resection

126

566

1.45

3.67

1.1

—

24.00

—

Acute tubulo-interstitial nephritis

495

1.53

3.60

1.1

—

33.63

u/ml

—

Reactive arthropathies

3.10

3.37

1.2

1.0

—

Hypermobility syndrome

3.94

3.28

1.2

1.1

—

u/ml

—

Chronic apical periodontitis

157

655

1.37

3.28

1.0

1.1

37.17

18.00

u/ml

—

Obesity due to excess calories

448

1.56

3.22

1.1

—

37.71

u/ml

—

Gonarthrosis, primary, with knee surgery

398

1.54

3.21

1.1

—

26.80

—

Temporal arteritis

5.36

3.19

1.3

1.1

—

Seronegative juvenile rheumatoid arthritis

6.41

3.19

1.1

1.2

—

u/ml

—

Other neurological diseases

521

1.46

3.17

1.1

—

42.33

u/ml

—

Migraine without aura

145

2.00

3.09

1.1

1.2

—

33.80

u/ml

—

Puerperal sepsis

113

2.13

2.99

1.2

1.1

—

Lung cancer and mesothelioma

2.28

2.99

1.0

1.1

—

Other and unspecified pemphigoid

10.13

2.99

1.6

1.2

—

Erythema intertrigo

10.05

2.98

1.0

1.2

—

Other/unspecified soft tissue disorders related to use, overuse and pressure

5.41

2.87

1.3

1.0

—

Intracranial injury

491

1.48

2.81

1.1

—

19.67

u/ml

—

Other symptoms and signs involving the circulatory and respiratory systems

3.01

2.69

1.4

1.2

—

Other disorders of urethra and urinary system

499

1.40

2.57

1.1

—

33.22

u/ml

—

Pulmonary eosinophilia, not elsewhere classified

7.21

2.55

1.2

1.1

—

Malignant neoplasm of cervix uteri

7.19

2.55

1.2

1.1

—

Flat foot [pes planus] (acquired)

2.73

2.54

1.2

1.0

—

Type 2 diabetes, definitions combined

131

574

1.34

2.54

1.1

—

39.43

u/ml

—

Type 2 diabetes, strict (exclude DM1)

131

576

1.34

2.49

1.1

—

39.43

u/ml

—

Diseases of veins, lymphatic vessels and lymph nodes, not elsewhere classified

127

608

1.34

2.48

1.1

—

39.43

u/ml

—

Erythema nodosum

4.39

2.47

1.0

1.1

—

Other general symptoms and signs

3.44

2.45

1.0

—

Type 2 diabetes

135

596

1.32

2.42

1.1

—

36.88

u/ml

—

Dizziness and giddiness

102

590

1.37

2.41

1.0

1.1

—

23.29

—

Hyperhidrosis

5.02

2.40

1.0

1.1

—

Cholelithiasis

113

577

1.35

2.39

1.0

1.1

—

34.50

u/ml

—

Eosinophilic disease (BM)

6.29

2.37

1.0

1.3

—

Causalgia

6.29

2.37

1.2

1.1

—

Giant cell arteritis

3.65

2.36

1.3

1.0

—

Tonsillectomy and adenotomy

342

1.45

2.24

1.2

1.1

—

26.25

u/ml

—

Cholelithiasis, broad definition with cholecystitis

116

587

1.33

2.24

1.1

—

34.50

u/ml

—

Secondary hypertension

2.72

2.23

1.0

1.2

—

Diabetes, varying definitions

137

618

1.30

2.20

1.1

—

36.88

u/ml

—

All anxiety disorders

459

1.39

2.16

1.1

—

29.67

u/ml

—

Retained placenta and membranes, without haemorrhage

2.07

2.16

1.2

1.1

—

Other and unspecified disease of Bartholin gland

3.70

2.15

1.0

1.2

—

Emphysema

2.71

2.07

1.0

1.1

—

Other deformities of toe(s)

4.01

2.04

1.0

—

Appendectomy

607

1.36

2.00

1.1

—

36.88

u/ml

—

Type 2 diabetes, definitions combined, including avohilmo

128

577

1.29

2.00

1.1

—

39.43

u/ml

—

Diseases of middle ear and mastoid

421

1.40

1.99

1.1

—

26.29

u/ml

—

Respiratory insufficiency

2.81

1.99

1.0

1.1

—

Diabetes mellitus

136

621

1.28

1.98

1.1

—

36.88

u/ml

—

Oligomenorrhoea

3.34

1.96

1.3

1.0

—

Anxiety (asthma-related co-morbidities)

458

1.37

1.96

1.1

—

20.86

u/ml

—

Other disorders of veins

384

1.45

1.94

1.1

—

39.43

u/ml

—

Anaemia in chronic diseases classified elsewhere

4.56

1.94

1.2

—

Female infertility, associated with anovulation

2.45

1.93

1.1

—

Varicose veins

449

1.36

1.91

1.1

—

24.00

u/ml

—

Primary gonarthrosis, bilateral

381

1.42

1.90

1.1

—

26.80

—

Intrahepatic Cholestasis of Pregnancy (ICP) , excluding more controls

2.40

1.85

1.2

1.1

—

u/ml

—

Malignant neoplasm of cervix uteri, including Hilmo

3.54

1.84

1.2

1.1

—

Lichen simplex chronicus

4.18

1.82

1.4

1.1

—

Paroxysmal tachycardia

120

1.74

1.82

1.1

—

Benign neoplasm: Other/unspecified site

3.87

1.72

1.2

—

Atopic dermatitis, strict definition

229

1.54

1.69

1.1

—

30.17

u/ml

—

Medical abortion

375

1.32

1.66

1.0

1.1

—

37.71

u/ml

—

Open bite

2.59

1.66

1.0

1.1

—

Other specified/unspecified soft tissue disorders

2.81

1.65

1.0

—

Perioral dermatitis

3.59

1.61

1.0

1.1

—

Algoneurodystrophy

3.01

1.58

1.2

1.1

—

Benign neoplasms

123

541

1.25

1.57

1.1

—

24.40

u/ml

—

Unspecified fall

433

1.37

1.55

1.1

—

19.67

u/ml

—

Viral and other specified intestinal infections

200

1.54

1.0

1.1

—

33.80

u/ml

—

Unspecified chronic bronchitis

3.34

1.52

1.0

1.1

—

Injuries to the shoulder and upper arm

102

649

1.27

1.51

1.1

—

31.00

u/ml

—

Intrahepatic Cholestasis of Pregnancy (ICP)

2.08

1.38

1.2

1.1

—

u/ml

—

Excessive attrition of teeth

528

1.31

1.37

1.0

1.1

—

31.00

u/ml

—

Female infertility, tubal origin

2.61

1.36

1.2

1.1

—

Obesity, other/unspecified

307

1.40

1.33

1.0

1.1

—

32.50

—

All dysplastic lesions of the vagina

2.79

1.28

1.2

1.1

—

Postmenopausal osteoporosis with pathological fracture

2.09

1.27

1.1

1.0

—

Other (not insulin) diabetes medications

124

605

1.22

1.27

1.1

—

39.43

u/ml

—

Neoplasms

397

1.25

1.26

1.1

—

24.25

u/ml

—

Diabetic retinopathy, excluding more controls

111

1.52

1.26

1.1

—

u/ml

—

Diabetic nephropathy, excluding more controls

1.73

1.25

1.1

—

Pustulosis palmaris et plantaris

2.40

1.24

1.0

—

Nonsuppurative otitis media

140

1.55

1.23

1.2

1.1

—

9.80

u/ml

—

Bronchiectasis

1.97

1.22

1.1

—

Failed induction of labour

2.11

1.18

1.0

1.1

—

Polycystic ovarian syndrome

2.05

1.15

1.0

1.1

—

Diabetes medication

130

646

1.19

1.13

1.1

—

36.88

u/ml

—

Acute suppurative otitis media

178

1.47

1.13

1.0

1.1

—

30.17

u/ml

—

Cardiac arrest

2.22

1.08

1.0

1.1

—

Type 2 diabetes, wide definition

488

1.22

1.05

1.1

—

24.00

u/ml

—

Diabetic nephropathy

112

1.59

1.03

1.1

—

Recurrent dislocation of patella

2.28

1.03

1.0

1.1

—

Twin gestation

1.84

1.02

1.1

—

Excessive vomiting in pregnancy

1.77

1.00

1.2

1.1

—

Pathological/recurrent dislocation and subluxation of joint, not elsewhere classified

2.00

1.00

1.0

—

Ovarian dysfunction

1.85

0.96

1.1

—

Multiple delivery

1.77

0.94

1.1

—

Multiple gestation

1.78

0.94

1.1

—

Autoimmune hyperthyroidism

2.22

0.93

1.0

—

Myocarditis

2.22

0.93

1.3

—

u/ml

—

Diabetes, insuline treatment (Kela reimbursement), excluding more controls

112

573

1.18

0.90

1.1

—

36.88

—

Other obstructed labour

1.72

0.86

1.2

1.1

—

Intrahepatic Cholestasis of Pregnancy (ICP) , incl. ICD-8, excluding more controls

1.72

0.86

1.2

1.1

—

u/ml

—

Other disorders of breast

114

1.49

0.79

1.1

—

Prolapse and hernia of ovary and fallopian tube

0.00

0.79

0.0

1.0

—

Diabetes, insulin treatment (Kela reimbursement)

119

623

1.15

0.77

1.1

—

36.88

—

Exclusions for E4_PCOS_CONSORTIUM

490

1.18

0.76

1.1

—

26.78

u/ml

—

Disorders of vitreous body and globe

465

1.22

0.76

1.1

—

26.80

—

Infections with a predominantly sexual mode of transmission

244

1.31

0.74

1.1

—

33.80

u/ml

—

Disorders of ocular muscles, binocular movement, accommodation and refraction

428

1.23

0.74

1.1

—

26.25

u/ml

—

Acute appendicitis, no complications

530

1.20

0.73

1.0

1.1

—

32.29

u/ml

—

Amenorrhoea

1.75

0.71

1.3

1.1

—

Cyst of Bartholin Gland

1.93

0.70

1.0

1.1

—

Suppurative and unspecified otitis media

273

1.27

0.70

1.0

1.1

—

30.17

u/ml

—

Biguanides

114

607

1.14

0.69

1.1

—

39.43

u/ml

—

Endometriosis diagnosis and infertility diagnosis occurring together

1.53

0.68

1.3

1.1

—

Placenta praevia

1.85

0.68

1.2

1.1

—

Personality disorders

213

1.32

0.68

1.0

1.1

—

33.80

u/ml

—

Insulin medication

444

1.19

0.67

1.1

—

42.33

u/ml

—

Infections of breast associated with childbirth

1.79

0.66

1.0

1.1

—

COPD-related respiratory insufficiency

1.54

0.65

1.0

—

Insulin, combination of fast acting with intermediate-acting or long-acting

485

1.19

0.64

1.1

—

47.00

u/ml

—

Intrahepatic Cholestasis of Pregnancy (ICP) , incl. ICD-8

1.55

0.62

1.2

1.1

—

u/ml

—

Recurrent dislocation and subluxation of joint

1.67

0.61

1.0

—

Other noninflammatory disorders of vagina

1.57

0.60

1.1

—

Cholecystectomy

614

1.15

0.59

1.0

1.1

—

39.43

u/ml

—

Pregnancy with abortive outcome

380

1.15

0.58

1.1

—

33.38

u/ml

—

Disorders of vitreous body

461

1.17

0.53

1.1

—

26.80

—

Other sexually transmitted chlamydial diseases

1.50

0.51

1.0

1.1

—

Infections with a predominantly sexual mode of transmission

310

1.20

0.50

1.1

—

30.17

u/ml

—

Other and unspecified disorders of vitreous body

383

1.18

0.50

1.1

—

26.80

—

Malignant neoplasm of corpus uteri, including Hilmo

0.61

0.45

1.0

1.1

—

Diseases of appendix

661

1.12

0.43

1.0

1.1

—

36.88

u/ml

—

Disorders of adult personality and behaviour

221

1.22

0.42

1.0

1.1

—

30.17

u/ml

—

Enterobiasis

0.00

0.41

0.0

1.1

—

Maternal infectious and parasitic diseases classifiable elsewhere but complicating pregnancy, childbirth and the puerperium

0.00

0.41

0.0

1.1

—

Autism spe

0.00

0.41

0.0

1.1

—

Wide developmental disorders, excluding more controls

0.00

0.41

0.0

1.1

—

Autism

0.00

0.40

0.0

1.1

—

Mental and behavioural disorders due to use of other stimulants, including caffeine

0.00

0.40

0.0

1.1

—

Acute appendicitis

636

1.12

0.40

1.0

1.1

—

36.88

u/ml

—

Wide developmental disorders

0.00

0.40

0.0

1.1

—

Persons encountering health services in circumstances related to reproduction

357

0.87

0.39

1.0

1.1

—

8.86

u/ml

—

Postpartum haemorrhage

189

1.20

0.37

1.1

—

36.60

—

Gestational [pregnancy-induced] oedema and proteinuria without hypertension

1.36

0.36

1.0

1.1

—

Exposure to other specified factors

683

1.10

0.35

1.0

1.1

—

31.00

—

Postpartum hemorraghe, all women as controls

223

1.19

0.34

1.1

—

36.60

—

Appendicitis, broad definition

657

1.10

0.34

1.0

1.1

—

36.88

u/ml

—

Labour and delivery complicated by umbilical cord complications

1.36

0.34

1.0

—

Injuries to the knee and lower leg

138

714

1.07

0.32

1.1

—

28.45

u/ml

—

Bronchitis, not specified as acute or chronic

1.35

0.31

1.1

—

Diabetic retinopathy

176

1.13

0.24

1.1

—

u/ml

—

Exposure to unspecified factor

111

752

1.06

0.23

1.1

—

28.45

u/ml

—

Unspecified abortion

1.28

0.23

1.0

1.1

—

Antenatal screening

113

0.84

0.22

1.0

1.2

—

9.40

u/ml

—

Unspecified lump in breast

135

0.81

0.22

1.1

—

Other and unspecified disorders of psychological development

0.00

0.21

0.0

1.1

—

Caries in Clefts patients

0.00

0.21

0.0

1.2

—

Other diseases caused by chlamydiae

0.00

0.21

0.0

1.2

—

Carcinoma in situ of cervix uteri, endocervix

0.00

0.21

0.0

1.2

—

Conotruncal defects

0.00

0.21

0.0

1.2

—

Hydatidiform mole

0.00

0.21

0.0

1.1

—

Abnormal findings in nipple discharge synovial fluid wound secretions

0.00

0.21

0.0

1.2

—

Diseases caused by chlamydiae

0.00

0.21

0.0

1.2

—

Mandibular prognathia

0.00

0.21

0.0

1.2

—

Cleft lip, lip and palate or palate

0.00

0.21

0.0

1.2

—

Other infestations

0.00

0.21

0.0

1.2

—

Use of amantadine

0.00

0.21

0.0

1.2

—

Behavioural disorders, excluding more controls

0.00

0.21

0.0

1.1

—

Disorders in reading

0.00

0.21

0.0

1.1

—

Human immunodeficiency virus [HIV] disease resulting in other conditions

0.00

0.21

0.0

1.2

—

Poisoning by narcotics and psychodysleptics [hallucinogens]

0.00

0.21

0.0

1.2

—

Habit and impulse disorders

0.00

0.21

0.0

1.1

—

Human immunodeficiency virus [HIV] disease

0.00

0.21

0.0

1.2

—

Benign neoplasm: Vulva

0.00

0.21

0.0

1.2

—

Habitual aborter

0.00

0.21

0.0

1.1

—

Mixed disorders of conduct and emotions, excluding more controls

0.00

0.21

0.0

1.0

—

Malignant neoplasm of other and unspecified female genital organs

0.00

0.21

0.0

1.1

—

Carcinoma in situ of other and unspecified genital organs

0.00

0.21

0.0

1.2

—

Mixed disorders of conduct and emotions

0.00

0.21

0.0

1.1

—

Other and unspecified mental retardation

0.00

0.21

0.0

1.2

—

Anorexia

0.00

0.21

0.0

1.2

—

Other diseases caused by chlamydiae

0.00

0.21

0.0

1.2

—

Other disorders of breast and lactation associated with childbirth

0.00

0.21

0.0

1.1

—

Behavioural disorders

0.00

0.21

0.0

1.2

—

Conduct disorder

0.00

0.21

0.0

1.1

—

Assault by unspecified means

0.00

0.20

0.0

1.1

—

Autism spe, excluding more controls

0.00

0.20

0.0

1.1

—

Mental and behavioural disorders due to cannabinoids

0.00

0.20

0.0

1.1

—

Diabetes mellitus in pregnancy

193

0.90

0.18

1.1

—

32.50

u/ml

—

Other noninflammatory disorders of vulva and perineum

1.19

0.18

1.0

1.1

—

Infections of genitourinary tract in pregnancy

1.22

0.17

1.0

1.1

—

Carcinoma in situ of cervix uteri

0.76

0.17

1.0

1.1

—

Procreative management

219

1.10

0.16

1.1

—

9.40

u/ml

—

Dislocation, sprain and strain of joints and ligaments of knee

550

0.94

0.16

1.1

—

31.00

—

Adenomyosis (Endometriosis of uterus)

111

1.17

0.15

1.2

1.1

—

Benign neoplasm of ovary

160

0.87

0.14

1.1

—

Other abnormal products of conception

201

1.09

0.14

1.2

1.1

—

36.60

—

Tooth eruption problems

102

1.15

0.11

1.2

1.1

—

9.80

u/ml

—

Fracture of lower leg, including ankle

527

1.05

0.11

1.0

1.1

—

36.88

—

Benign neoplasm of breast

115

0.87

0.10

1.0

1.1

—

Care involving use of rehabilitation procedures

565

1.04

0.09

1.1

—

34.88

u/ml

—

Gestational diabetes (for exclusion)

244

0.94

0.09

1.1

—

36.60

u/ml

—

Inflammatory disease of cervix uteri

1.11

0.09

1.0

1.1

—

Antepartum haemorrhage, not elsewhere classified

1.09

0.08

1.1

—

u/ml

—

Diabetic maculopathy

1.13

0.08

1.2

1.1

—

Maternal care for other conditions predominantly related to pregnancy

183

1.07

0.06

1.1

—

36.60

u/ml

—

Later onset COPD

183

1.04

0.03

1.0

1.1

—

Other maternal disorders predominantly related to pregnancy

388

1.02

0.02

1.1

—

33.11

u/ml

—

Diabetic retinopathy, strict definition

117

1.06

0.02

1.1

—

Pervasive developmental disorders excl. Autism + Asperger

0.00

0.0

1.0

—

Endometroid carcinoma of ovary, including Hilmo

0.00

0.0

1.0

—

Benign neoplasm: Endocrine gland, other/unspecified

0.00

0.0

1.2

—

Precocious central puberty

0.00

0.0

1.2

—

Drug-induced obesity

0.00

0.0

1.3

—

Disorder of thyroid, unspecified

0.00

0.0

1.1

—

Schizoid personality disorder

0.00

0.0

1.1

—

Ascariasis

0.00

0.0

1.2

—

Specific developmental disorder of motor function

0.00

0.0

1.3

—

Other and unspecified neuropathies

0.00

0.0

1.2

—

Other acute disseminated demyelination

0.00

0.0

1.3

—

Social disorders starting during childhood or adolescence

0.00

0.0

1.3

—

Mandibular prognathia AND surgery (LeFortI or BSSO)

0.00

0.0

1.3

—

Respiratory and cardiovascular disorders specific to the perinatal period

0.00

0.0

1.3

—

Use of cabergoline

0.00

0.0

1.1

—

Congenital musculoskeletal deformities of head, face, spine and chest

0.00

0.0

1.2

—

Other osteochondrodysplasias

0.00

0.0

1.3

—

Delayed milestone in childhood

0.00

0.0

1.0

—

Toxic effect of other noxious substances eaten as food

0.00

0.0

1.0

—

Injury of blood vessels at abdomen, lower back and pelvis level

0.00

0.0

1.2

—

Other injuries of upper limb, level unspecified

0.00

0.0

1.3

—

Motor disorders, excluding more controls

0.00

0.0

1.2

—

Motor- or nonmotor-vehicle accident in traffic area

0.00

0.0

1.2

—

Occupant of pick-up truck or van injured in other and unspecified transport accidents

0.00

0.0

1.3

—

Fall involving playground equipment

0.00

0.0

1.2

—

Pedestrian injured in other and unspecified transport accidents

0.00

0.0

1.3

—

Fitting and adjustment of external prosthetic device

0.00

0.0

1.0

—

Serous carcinoma of ovary

0.00

0.0

1.0

—

Benign neoplasm: Bones of skull and face

0.00

0.0

1.3

—

Acute disseminated encephalitis/encephalomyelitis

0.00

0.0

1.2

—

Chronic myeloid leukaemia

0.00

0.0

1.0

—

Cleft lip and cleft lip and palate

0.00

0.0

1.2

—

Benign neoplasm: Tonsil

0.00

0.0

1.1

—

Enterobiasis

0.00

0.0

1.3

—

Metabolic disorder, other/unspecified

0.00

0.0

1.2

—

Benign lipomatous neoplasm of skin and subcutaneous tissue of other and unspecified sites

0.00

-0.00

0.0

1.2

—

Benign neoplasm: Connective and other soft tissue of thorax

0.00

-0.00

0.0

1.3

—

Infarction of spleen

0.00

-0.00

0.0

1.0

—

Carcinoma in situ of breast

0.00

-0.00

0.0

1.3

—

Other zoonotic bacterial diseases, not elsewhere classified

0.00

-0.00

0.0

1.2

—

Melanoma in situ of lower limb, including hip

0.00

-0.00

0.0

1.2

—

Cervical root disorders

0.00

-0.00

0.0

1.0

—

Paget disease

0.00

-0.00

0.0

1.2

—

Melanocytic naevi of lip

0.00

-0.00

0.0

1.3

—

Abnormality of white blood cells, not elsewhere classified

0.00

-0.00

0.0

1.2

—

Polyarteritis nodosa

0.00

-0.00

0.0

1.3

—

Acromegaly and pituitary gigantism

0.00

-0.00

0.0

1.2

—

Fetus and newborn affected by maternal factors and by complications of pregnancy, labour and delivery

0.00

-0.00

0.0

1.0

—

Benign neoplasm: Ribs, sternum and clavicle

0.00

-0.00

0.0

1.2

—

Carcinoma in situ of breast, other/unspecified

0.00

-0.00

0.0

1.1

—

Thalassaemia

0.00

-0.00

0.0

1.2

—

Right ventricular outflow tract obstruction

0.00

-0.00

0.0

1.4

—

Motor disorders

0.00

-0.00

0.0

1.3

—

Vascular dementia (multiple infarctions)

0.00

-0.00

0.0

1.0

—

Benign neoplasm of soft tissue of retroperitoneum and peritoneum

0.00

-0.00

0.0

1.2

—

Unspecified human immunodeficiency virus [HIV] disease

0.00

-0.00

0.0

1.3

—

Diabetic neuropathy

0.97

-0.00

1.0

1.1

—

Neuroendocrine tumor and carcinoma of lung

0.00

-0.00

0.0

1.0

—

Severe combined immunodeficiency [SCID] with reticular dysgenesis

0.00

-0.00

0.0

1.2

—

Acquired stenosis of external ear canal

0.00

-0.00

0.0

1.1

—

Social disorders starting during childhood or adolecense, excluding more controls

0.00

-0.00

0.0

1.2

—

0.00

-0.00

0.0

1.4

—

Other hereditary haemolytic anaemias

0.00

-0.00

0.0

1.3

—

Clubfoot

0.00

-0.00

0.0

1.3

—

Prominent ears

0.00

-0.00

0.0

1.4

—

Right side

0.00

-0.00

0.0

1.2

—

Previous suicide attempt

0.00

-0.00

0.0

1.3

—

Personal history of allergy to drugs, medicaments and biological substances

0.00

-0.00

0.0

1.3

—

Left side

0.00

-0.00

0.0

1.2

—

Open bite that required surgery (Lefort1 or BSSO)

0.00

-0.00

0.0

1.3

—

Hand

0.00

-0.00

0.0

1.2

—

Routine general health check-up of defined subpopulation

0.00

-0.00

0.0

1.0

—

Personal history of allergy to analgesic agent

0.00

-0.00

0.0

1.2

—

≡ Risteys

R13

FinnGen R12 + FinRegistry

FinnGen R11 + FinRegistry

FinnGen R10 + FinRegistry

FinnGen R10

FinnGen R9

FinnGen R8

FinnGen R7

FinnGen R6

FinnGen R5

FinnGen R4

FinnGen R3

Histone Ab [Units/volume] in Serum

Coding

Definition

OMOP mapping QC

Cohort

Year of birth distribution

Age at first measurement

Age at last measurement

Age at start of registry

Duration from first to last measurement

Statistics

Number of measurements over the years

Number of measurements per person

Distribution of lab values

Value range per person

LabWAS